vs
Side-by-side financial comparison of AdvanSix Inc. (ASIX) and Mistras Group, Inc. (MG). Click either name above to swap in a different company.
AdvanSix Inc. is the larger business by last-quarter revenue ($359.9M vs $181.5M, roughly 2.0× Mistras Group, Inc.). Mistras Group, Inc. runs the higher net margin — 2.1% vs -0.8%, a 2.8% gap on every dollar of revenue. On growth, AdvanSix Inc. posted the faster year-over-year revenue change (9.4% vs 5.1%). AdvanSix Inc. produced more free cash flow last quarter ($36.1M vs $26.0M). Over the past eight quarters, AdvanSix Inc.'s revenue compounded faster (3.4% CAGR vs -0.8%).
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
Mistras Group, Inc. is a global provider of asset integrity and protection solutions, offering non-destructive testing, inspection, real-time monitoring, and engineering consulting services. Its key client segments include oil and gas, aerospace, power generation, and manufacturing industries, with operations spanning North America, Europe, and Asia-Pacific, helping clients enhance operational safety, extend asset lifespans, and minimize unplanned downtime.
ASIX vs MG — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $359.9M | $181.5M |
| Net Profit | $-2.8M | $3.8M |
| Gross Margin | 7.6% | 28.4% |
| Operating Margin | -0.7% | 7.0% |
| Net Margin | -0.8% | 2.1% |
| Revenue YoY | 9.4% | 5.1% |
| Net Profit YoY | -892.9% | -27.4% |
| EPS (diluted) | $-0.11 | $0.12 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $359.9M | $181.5M | ||
| Q3 25 | $374.5M | $195.5M | ||
| Q2 25 | $410.0M | $185.4M | ||
| Q1 25 | $377.8M | $161.6M | ||
| Q4 24 | $329.1M | $172.7M | ||
| Q3 24 | $398.2M | $182.7M | ||
| Q2 24 | $453.5M | $189.8M | ||
| Q1 24 | $336.8M | $184.4M |
| Q4 25 | $-2.8M | $3.8M | ||
| Q3 25 | $-2.6M | $13.1M | ||
| Q2 25 | $31.4M | $3.0M | ||
| Q1 25 | $23.3M | $-3.2M | ||
| Q4 24 | $352.0K | $5.2M | ||
| Q3 24 | $22.3M | $6.4M | ||
| Q2 24 | $38.9M | $6.4M | ||
| Q1 24 | $-17.4M | $995.0K |
| Q4 25 | 7.6% | 28.4% | ||
| Q3 25 | 6.8% | 29.8% | ||
| Q2 25 | 14.3% | 29.1% | ||
| Q1 25 | 14.2% | 25.3% | ||
| Q4 24 | 3.4% | 26.5% | ||
| Q3 24 | 14.4% | 26.8% | ||
| Q2 24 | 17.9% | 27.1% | ||
| Q1 24 | 0.9% | 25.0% |
| Q4 25 | -0.7% | 7.0% | ||
| Q3 25 | -0.9% | 10.4% | ||
| Q2 25 | 7.7% | 4.5% | ||
| Q1 25 | 7.7% | -0.6% | ||
| Q4 24 | -3.9% | 6.1% | ||
| Q3 24 | 7.5% | 6.5% | ||
| Q2 24 | 11.5% | 6.3% | ||
| Q1 24 | -7.0% | 3.0% |
| Q4 25 | -0.8% | 2.1% | ||
| Q3 25 | -0.7% | 6.7% | ||
| Q2 25 | 7.7% | 1.6% | ||
| Q1 25 | 6.2% | -2.0% | ||
| Q4 24 | 0.1% | 3.0% | ||
| Q3 24 | 5.6% | 3.5% | ||
| Q2 24 | 8.6% | 3.4% | ||
| Q1 24 | -5.2% | 0.5% |
| Q4 25 | $-0.11 | $0.12 | ||
| Q3 25 | $-0.10 | $0.41 | ||
| Q2 25 | $1.15 | $0.10 | ||
| Q1 25 | $0.86 | $-0.10 | ||
| Q4 24 | $0.02 | $0.17 | ||
| Q3 24 | $0.82 | $0.20 | ||
| Q2 24 | $1.43 | $0.20 | ||
| Q1 24 | $-0.65 | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $19.8M | $28.0M |
| Total DebtLower is stronger | — | $178.0M |
| Stockholders' EquityBook value | $815.2M | $235.1M |
| Total Assets | $1.7B | $578.8M |
| Debt / EquityLower = less leverage | — | 0.76× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.8M | $28.0M | ||
| Q3 25 | $23.7M | $27.8M | ||
| Q2 25 | $18.4M | $20.0M | ||
| Q1 25 | $8.3M | $18.5M | ||
| Q4 24 | $19.6M | $18.3M | ||
| Q3 24 | $17.3M | $20.4M | ||
| Q2 24 | $12.1M | $17.2M | ||
| Q1 24 | $20.6M | $16.9M |
| Q4 25 | — | $178.0M | ||
| Q3 25 | — | $202.3M | ||
| Q2 25 | — | $189.4M | ||
| Q1 25 | — | $171.9M | ||
| Q4 24 | — | $169.6M | ||
| Q3 24 | — | $189.7M | ||
| Q2 24 | — | $199.7M | ||
| Q1 24 | — | $198.4M |
| Q4 25 | $815.2M | $235.1M | ||
| Q3 25 | $818.2M | $227.4M | ||
| Q2 25 | $823.7M | $215.8M | ||
| Q1 25 | $794.4M | $198.7M | ||
| Q4 24 | $774.6M | $198.6M | ||
| Q3 24 | $766.4M | $205.2M | ||
| Q2 24 | $746.6M | $193.2M | ||
| Q1 24 | $713.2M | $187.1M |
| Q4 25 | $1.7B | $578.8M | ||
| Q3 25 | $1.7B | $596.3M | ||
| Q2 25 | $1.6B | $571.0M | ||
| Q1 25 | $1.6B | $526.8M | ||
| Q4 24 | $1.6B | $523.0M | ||
| Q3 24 | $1.5B | $551.7M | ||
| Q2 24 | $1.5B | $548.1M | ||
| Q1 24 | $1.5B | $542.1M |
| Q4 25 | — | 0.76× | ||
| Q3 25 | — | 0.89× | ||
| Q2 25 | — | 0.88× | ||
| Q1 25 | — | 0.87× | ||
| Q4 24 | — | 0.85× | ||
| Q3 24 | — | 0.92× | ||
| Q2 24 | — | 1.03× | ||
| Q1 24 | — | 1.06× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $63.7M | $32.1M |
| Free Cash FlowOCF − Capex | $36.1M | $26.0M |
| FCF MarginFCF / Revenue | 10.0% | 14.3% |
| Capex IntensityCapex / Revenue | 7.7% | 3.4% |
| Cash ConversionOCF / Net Profit | — | 8.55× |
| TTM Free Cash FlowTrailing 4 quarters | $6.4M | $8.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.7M | $32.1M | ||
| Q3 25 | $26.6M | $4.5M | ||
| Q2 25 | $21.1M | $-9.3M | ||
| Q1 25 | $11.4M | $5.6M | ||
| Q4 24 | $64.2M | $25.7M | ||
| Q3 24 | $57.3M | $19.4M | ||
| Q2 24 | $50.2M | $4.5M | ||
| Q1 24 | $-36.2M | $604.0K |
| Q4 25 | $36.1M | $26.0M | ||
| Q3 25 | $66.0K | $-4.1M | ||
| Q2 25 | $-7.2M | $-14.7M | ||
| Q1 25 | $-22.6M | $1.1M | ||
| Q4 24 | $29.8M | $22.1M | ||
| Q3 24 | $26.8M | $14.6M | ||
| Q2 24 | $16.7M | $-284.0K | ||
| Q1 24 | $-71.6M | $-4.2M |
| Q4 25 | 10.0% | 14.3% | ||
| Q3 25 | 0.0% | -2.1% | ||
| Q2 25 | -1.7% | -7.9% | ||
| Q1 25 | -6.0% | 0.7% | ||
| Q4 24 | 9.1% | 12.8% | ||
| Q3 24 | 6.7% | 8.0% | ||
| Q2 24 | 3.7% | -0.1% | ||
| Q1 24 | -21.3% | -2.3% |
| Q4 25 | 7.7% | 3.4% | ||
| Q3 25 | 7.1% | 4.4% | ||
| Q2 25 | 6.9% | 2.9% | ||
| Q1 25 | 9.0% | 2.8% | ||
| Q4 24 | 10.4% | 2.1% | ||
| Q3 24 | 7.7% | 2.6% | ||
| Q2 24 | 7.4% | 2.5% | ||
| Q1 24 | 10.5% | 2.6% |
| Q4 25 | — | 8.55× | ||
| Q3 25 | — | 0.34× | ||
| Q2 25 | 0.67× | -3.07× | ||
| Q1 25 | 0.49× | — | ||
| Q4 24 | 182.29× | 4.96× | ||
| Q3 24 | 2.57× | 3.02× | ||
| Q2 24 | 1.29× | 0.71× | ||
| Q1 24 | — | 0.61× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
MG
Segment breakdown not available.
